BMSN on CNBC website!!! Listed in the same pipeline review as GlaxoSmithKline (the world's 4th largest pharmaceutical company and $133.4 billion market cap), Pluristem Therapeutics ($258.6 million market cap), and Aprogen (a privately owned South Korean company).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.